Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 3100Neoplasms 2446Carcinoma, Non-Small-Cell Lung 1865Prostatic Neoplasms 1629Colorectal Neoplasms 1424Lung Neoplasms 1300Multiple Myeloma 930Neoplasm Metastasis 926Leukemia, Myeloid, Acute 874Pancreatic Neoplasms 851Ovarian Neoplasms 803Melanoma 786Carcinoma, Hepatocellular 743Stomach Neoplasms 640Brain Neoplasms 640Recurrence 635Squamous Cell Carcinoma of Head and Neck 631Head and Neck Neoplasms 614Glioblastoma 569Lymphoma 543Uterine Cervical Neoplasms 541Triple Negative Breast Neoplasms 505Precursor Cell Lymphoblastic Leukemia-Lymphoma 498Carcinoma, Renal Cell 497Hematologic Neoplasms 467Urinary Bladder Neoplasms 462Endometrial Neoplasms 462Colonic Neoplasms 439Sarcoma 437Lymphoma, Non-Hodgkin 437

Interventions

Pharmaceutical Preparations 1Irinotecan 1Fluorouracil 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
BRAF V600 Colorectal Cancer × 1 year × Clear all
NCT07150247 2025-09-26

Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer

Sun Yat-sen University

Phase 2 Recruiting
20 enrolled
Gastrointestinal

BRAF V600 Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡